The International Vaccine Institute (Director: John D. Clemens), the only international organization headquartered in Korea, will host a vaccinology training course for the Asia Pacific region at its new headquarters building on the campus of Seoul National University from March 8 to 13.
Some 40 scientists and public health officials from some 20 countries will attend the six-day training course, titled "the International Advanced Course on Vaccinology in Asia Pacific Regions." The course aims at strengthening the capacity of countries from the Asia-Pacific Regions in vaccinology by providing participants with a comprehensive overview of the vaccine continuum, from vaccine development, evaluation and regulatory principles, to production, introduction and policy issues.
A group of worldwide renowned vaccine experts will serve as lecturers for this year´s course. They include IVI Director Dr. John D. Clemens, Prof. Yoon-Ok Ahn of Seoul National University College of Medicine, Prof. Sung-Il Cho of the SNU School of Public Health, and Dr. Sue-Nie Park of the Korea Food & Drug Administration, as well as several officials from the World Health Organization, and other national experts.
It is the first time that the IVI holds this annual event at its headquarters, which was completed in June last year. Previously the training course was conducted in other countries such as Vietnam and Singapore. The training program, which marks the fourth occasion this year, is designed specifically for scientists, public health officials and decision-makers involved in vaccine development, vaccination strategies, and policy-making related with the introduction of new vaccines in public health programs at the national and international levels. The participants include people from both developing and developed countries such as Pakistan, Bangladesh, Australia and Singapore.
The IVI is the world´s only international organization devoted exclusively to the development and accelerated introduction of new and improved vaccines for the poor. The institute is also a member of the WHO Global Training Network for Vaccine Production and Regulation.
"One of the IVI´s most important mandates is to provide technical assistance and training to public health officials, scientists from local manufacturers, and policymakers from developing countries." Dr. John Clemens said. "The completion of our headquarters building generously donated by the Korean Government, with its state-of-the art laboratory facilities, will certainly expedite our efforts in this regard."
Specifically, the course will include lectures on "epidemiology," "immunobiology," "vaccine development and production," and "clinical evaluation, licensing and vaccine introduction issues." The participants will delve into, among others, ethical issues related to clinical evaluation of vaccines, communicating risk information about vaccination, and vaccination strategies for different target groups such as the elderly or pregnant women. The course will end with a keynote speech delivered by Prof. Ian Gust, a world´s authority in vaccinology and emeritus professor from the University of Melbourne.
The course is sponsored by GlaxoSmithkline, Rockefeller Foundation, Sartorius and the Bill and Melinda Gates Foundation.